Laird Norton Wetherby Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$580K Sell
7,912
-1,503
-16% -$99.8K 0.02% 526
2025
Q2
$490K Buy
+9,415
New +$536K 0.02% 571
2024
Q4
$542K Sell
11,339
-48
-0.4% -$2.46K 0.03% 499
2024
Q3
$652K Buy
11,387
+46
+0.4% +$2.64K 0.03% 475
2024
Q2
$594K Buy
11,341
+514
+5% +$22.5K 0.03% 488
2024
Q1
$440K Sell
10,827
-725
-6% -$27.2K 0.02% 599
2023
Q4
$427K Sell
11,552
-165
-1% -$6.21K 0.02% 599
2023
Q3
$448K Sell
11,717
-864
-7% -$35.4K 0.03% 559
2023
Q2
$454K Buy
12,581
+1,471
+13% +$50.2K 0.02% 573
2023
Q1
$424K Sell
11,110
-337
-3% -$15.8K 0.02% 596
2022
Q4
$651K Sell
11,447
-837
-7% -$42.9K 0.04% 426
2022
Q3
$486K Sell
12,284
-1,491
-11% -$65.9K 0.03% 504
2022
Q2
$606K Sell
13,775
-174
-1% -$7.53K 0.04% 433
2022
Q1
$556K Buy
13,949
+18
+0.1% +$641 0.03% 491
2021
Q4
$560K Sell
13,931
-57
-0.4% -$2.13K 0.03% 478
2021
Q3
$569K Sell
13,988
-64
-0.5% -$2.68K 0.04% 466
2021
Q2
$638K Buy
+14,052
New +$622K 0.04% 428
2021
Q1
Sell
-16,095
Closed -$687K 829
2020
Q4
$687K Buy
+16,095
New +$579K 0.05% 363

Other funds holding HALO

Laird Norton Wetherby Wealth Management's HALO Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management reduced its Halozyme (HALO) stake by 16% in Q3 2025, selling an estimated $99.8K and leaving 7,912 shares worth $580K. The position accounts for 0.02% of the portfolio, ranked #526.

Laird Norton Wetherby Wealth Management first reported a position in HALO in Q4 2020 and has held it in 18 quarters since. The position peaked at $687K in Q4 2020. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 7,912 shares of Halozyme worth $580K as of Q3 2025.
  • Laird Norton Wetherby Wealth Management sold 1,503 Halozyme shares in Q3 2025, an estimated $99.8K.
  • Halozyme made up 0.02% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #526 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Halozyme in Q4 2020 and has held it in 18 quarters since.
  • Laird Norton Wetherby Wealth Management's Halozyme position peaked at $687K in Q4 2020.
  • 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.